Cecilia Kållberg

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 6

Top Topics

Health Insurance

Antimicrobial Resistance

Helicobacter Pylori Infection

Top Venues

Journal of pharmaceutical policy and practice

ACS infectious diseases

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Cecilia Kållberg, Liv Mathiesen, Unni Gopinathan, Hege Salvesen Blix
The role of drug regulatory authorities and health technology assessment agencies in shaping incentives for antibiotic R&D: a qualitative study. Journal of pharmaceutical policy and practice 16 (1) (2023)
Cecilia Kållberg, Liv Mathiesen, Unni Gopinathan, Hege Salvesen Blix
The role of drug regulatory authorities and health technology assessment agencies in shaping incentives for antibiotic R&D: a qualitative study. Journal of pharmaceutical policy and practice 16 (1) (2023)
Cecilia Kållberg, Liv Mathiesen, Unni Gopinathan, Hege Salvesen Blix
The role of drug regulatory authorities and health technology assessment agencies in shaping incentives for antibiotic R&D: a qualitative study. Journal of pharmaceutical policy and practice 16 (1) (2023)
Cecilia Kållberg, Jemma Hudson, Hege Salvesen Blix, Christine Årdal, Eili Klein, Morten Lindbæk, Kevin Outterson, John-Arne Røttingen, Ramanan Laxminarayan
The effect of generic market entry on antibiotic prescriptions in the United States. Nature communications 12 (1) (2021)
Cecilia Kållberg, Hege Salvesen Blix, Ramanan Laxminarayan
Challenges in Antibiotic R&D Calling for a Global Strategy Considering Both Short- and Long-Term Solutions. ACS infectious diseases 5 (8) (2019)
Cecilia Kållberg, Christine Årdal, Hege Salvesen Blix, Eili Klein, Elena M Martinez, Morten Lindbæk, Kevin Outterson, John-Arne Røttingen, Ramanan Laxminarayan
Introduction and geographic availability of new antibiotics approved between 1999 and 2014. PloS one 13 (10) (2018)